Asthma drugs Flashcards
What mediates bronchoconstriction problems in asthma?
inflammatory processes and parasympathetic tone.
What are the beta-2 agonists? How do they differ in use and toxicity?
albuterol: used short term in a rescue inhaler
salmeterol/fometerol: used as long-term asthma prophylaxis. toxicity: arrhythmia and tremor
methylxanthines: mechanism and use
ex. theophylline. works by blocking phosphdiesterase, which is normally responsible for cAMP breakdown. this relaxes bronchial tone. Theophylline also blocks the effects of adenosine (which promotes bronchoconstriction)
use is limited because of narrow therapeutic range/toxicities (cardiotoxicity, neurotoxicity). (metabolized by P-450)
ipatropium: mechanism and use
this is a muscarinic antagonist. it competitively blocks muscarinic receptors to prevent bronchoconstriction.
it is also used for COPD
tiotropium is also used for COPD
What corticosteroids are used for asthma? How are they used, specifically?
fluticasone, beclomethasone.
these are inhaled steroids that are considered first-line treatment for chronic asthma.
they block the production of most cytokines by inactivating NF-kappaB. NF-kB is the transcription factor that induces the production of TNF-alpha and other inflammatory agents.
montelukast mechanism and use
(also zafirulkast)
this is an inhibitor of the leukotriene receptors that. it is particularly useful for aspirin-induced asthma.
ziluten mechanism and use
blocks the lipooxygenase pathway and reduces production of leukotrienes from arachidonic acid.
omalizumab: mechanism and use
this is a monoclonal antibody against IgE. it binds unbound serum IgE and blocks binding to the FCe receptors. used in allergic asthma that is resistant to inhaled steroids and long-acting beta 2 agonists
methacholine: mechanism and use
this is a muscarinic agonist that is used in bronchial provocation challenge to help in asthma diagnosis.
bosetan: mechanism and use
this is used to treat pulmonary arterial hypertension. it is a competitive antagonist of the endothelin-1 receptors and decreases pulmonary vascular resistance.